EcoGraf Limited (ASX: EGR; FSE: FMK) is pleased to announce the completion of its Independent Engineering Study ( ‘Study’) for the development of its TanzGraphite Mechanical Shaping Facility at ...
Muzastotug Phase 2 dose expansion in MSS CRC with a 20 mg/kg loading dose regimen shows 33% overall response rate with four confirmed partial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback